Search

everythinglearnresearchcommunity

for

Search:↓

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Baricitinib helps with early hair regrowth in people with alopecia areata.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Certain genes and proteins may help diagnose and treat primary cicatricial alopecia.

Baricitinib shows promise in treating severe hair loss.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Carbon Quantum Dots can effectively detect cobalt ions and methylcobalamin in water.

Using 120% sodium citrate in blood gives the best platelet recovery and enrichment.

A patient developed a blister at the injection site after hepatitis C treatment.

Combining betamethasone and PRP injections works best for treating alopecia areata.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

BioPlex-11 improves DNA profiling from telogen hair roots in forensic work.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

A boronic acid copolymer quickly forms cell clusters, useful for tissue and tumor modeling.

Certain SPINK5 gene mutations are common in Israeli families with Comèl-Netherton syndrome.

A nine-year-old girl with muscle weakness and total hair loss improved with specific treatments.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

RIPK1 inhibitors might help prevent alopecia areata.